Pages

▼
Thursday, August 18, 2022

Haunted by the Impunity of Rich Business Leaders - Will One Criminal Conviction make a Difference? The Trump Organization Chief Financial Officer Pleads Guilty

›
  Impunity: an Introduction We believe that unaccountable leadership is a major cause of health care dysfunction.  Impunity is an extreme...
Sunday, January 09, 2022

The New Business Coup? Increasing Evidence that Large Health Care Corporations are Funding Threats to Democracy

›
Introduction: Health Care Corporations' Political Contributions: From Bipartisan to Trumpian  At one time, leadership of large health c...
1 comment:
Friday, December 24, 2021

Guest Blog: Susan Levenstein, MD, on the Omicron Variant

›
To encourage wider dissemination, we're pleased to provide here an author-abridged and -authorized version of a recent number of the  St...
Saturday, December 04, 2021

The Irresponsibility of Political Leaders Encouraging Vaccine Resistance by Health Care Professionals: One Small Response to a Local Example

›
[Below is the text of a letter to the editor I wrote to the Providence Journal about one state legislator who praised the "joyful"...
Tuesday, November 23, 2021

The New New Abnormal: What Should We Do in a World Becoming Increasingly Irrational?

›
We Health Care Renewal ( http://hcrenewal.blogspot.com ) bloggers once again apologize for our chronic lack of posting on the blog. Howeve...
Tuesday, October 19, 2021

On the primacy of the physician-patient relationship, from an unlikely source - the Attorney General of Nebraska

›
I have not written much at this site, or any site, in recent years due to being kept busy supporting litigation regarding bad healthcare inf...
Tuesday, September 07, 2021

More Large Health Care Corporations Are Again Funding Politicians Who Threatened Representative Democratic Governance

›
Introduction: Health Care Corporations' Political Contributions: From Bipartisan to Trumpian  At one time, leadership of large health c...
1 comment:
Friday, July 23, 2021

Money and Aducanumab

›
In my previous posts, I haven't talked too much about the price set for aducanumab. Since I think it should not have been approved on c...
Thursday, July 08, 2021

The Future of Aducanumab - as a Medicine and as a Financial Product - What Happens Now?

›
To recap: the FDA recently (and foolishly) approved Biogen's monoclonal antibody aducanumab as a treatment for Alzheimer's. It did t...
Wednesday, July 07, 2021

Leadership of Big Health Care Corporations Go Back to Financially Supporting the Opponents of Democratic Governance

›
At one time, leadership of large health corporations were circumspect in their financial support for US politicians and political causes. T...
Wednesday, June 30, 2021

Aducanumab Approval, Part 2

›
So how did a drug with such dubious benefit get approved? At best, another clinical trial might be warranted, but certainly not approval. It...
1 comment: